Form

Sinopec Shanghai Petrochemical Company Limited Intends to Deregister and Terminate Its Reporting Obligations Under the U.S. Securities Exchange Act of 1934

Retrieved on: 
星期三, 四月 10, 2024

Sinopec Shanghai Petrochemical Company Limited Intends to Deregister and Terminate Its Reporting Obligations Under the U.S. Securities Exchange Act of 1934

Key Points: 
  • Sinopec Shanghai Petrochemical Company Limited Intends to Deregister and Terminate Its Reporting Obligations Under the U.S. Securities Exchange Act of 1934
    SHANGHAI, CHINA / EQS NEWSWIRE / March 15, 2024 – Sinopec Shanghai Petrochemical Company Limited (the “Company”) (HKEX:00338)(SSE:600688) announced today that the Company intends to deregister with the United States Securities and Exchange Commission (the “SEC”) and terminate its reporting obligations under the U.S. Securities Exchange Act of 1934, as amended (the “Exchange Act”).
  • Thereafter, all of the Company’s reporting obligations under the Exchange Act will be suspended unless the Form 15F is withdrawn or denied.
  • Deregistration and termination of the Company’s reporting obligations under the Exchange Act are expected to become effective 90 days after its filing of Form 15F.
  • This press release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended.

ANNOUNCEMENT OF INVITATION TO VOLUNTARY TENDER OFFER TO THE HOLDERS OF X5 RETAIL GROUP N.V., GLOBAL DEPOSITARY RECEIPTS – ISIN US98387E2054

Retrieved on: 
星期三, 四月 10, 2024

The date and time by which holders must validly tender Securities in order to be eligible to receive an Acceptance Notice and instruct a settlement.

Key Points: 
  • The date and time by which holders must validly tender Securities in order to be eligible to receive an Acceptance Notice and instruct a settlement.
  • As soon as reasonably possible from receipt of an Acceptance Form, that is confirmed by the Offeror to be valid.
  • Holders that wish to accept the Offer are requested to complete the Form of Acceptance and send this directly to the Offeror via email to [email protected] .
  • Forms of Acceptance received by the 6th of May 2024 will receive a Confirmation Notice.

ANNOUNCEMENT OF INVITATION TO VOLUNTARY TENDER OFFER TO THE HOLDERS OF GLOBALTRANS INVESTMENT PLC GDR's - US37949E2046

Retrieved on: 
星期三, 四月 10, 2024

The date and time by which holders must validly tender Securities in order to be eligible to receive the relevant Purchase Price on the Settlement Date.

Key Points: 
  • The date and time by which holders must validly tender Securities in order to be eligible to receive the relevant Purchase Price on the Settlement Date.
  • As soon as reasonably possible from receipt of an Acceptance Form, that is confirmed by the Offeror to be valid.
  • Holders that wish to accept the Offer are requested to complete the Form of Acceptance and send this directly to the Offeror via email to [email protected] .
  • Forms of Acceptance received by the 6th of May 2024 will receive a Confirmation Notice.

The Board of Directors comments on zCapital’s proposals

Retrieved on: 
星期三, 四月 10, 2024

Baloise’s Board of Directors encourages shareholders to vote and recommends zCapital’s proposals be rejected.

Key Points: 
  • Baloise’s Board of Directors encourages shareholders to vote and recommends zCapital’s proposals be rejected.
  • The Board offers the prospect to amend the corresponding provisions of the articles of association at the 2025 General Meeting.
  • On the 21st of February 2024, asset manager zCapital has submitted proposals to the Board of Directors, according to which the registration and voting rights restriction in the articles of associations is to be lifted.
  • In preparation for this statement, the Board of Directors has initiated the discussion with shareholders and other stakeholders.

Argo's Year-End 2023 Oil Reserves Report

Retrieved on: 
星期一, 四月 8, 2024

(2) "Net Reserves" are the Company's working interest reserves after deductions of royalty obligations, plus the Company's royalty interests.

Key Points: 
  • (2) "Net Reserves" are the Company's working interest reserves after deductions of royalty obligations, plus the Company's royalty interests.
  • The disclosures contained in this report represent information related to the Company's reserves, future net revenue, and discounted value of future net cash flows as of December 31, 2023.
  • The report does not include the second planned oil well at Lloydminster, as this was not confirmed until Q1 2024.
  • The Company will be filing its Form 51-101 F1 Statement of Reserves Data and Other Oil and Gas Information ("Form F1"), Form 51-101 F2 Report on Reserves Data by Independent Qualified Reserves Evaluator ("Form F2"), and Form 51-101 F3 Report of Management and Directors on Oil and Gas Disclosure ("Form F3") for the year ending December 31, 2023, shortly.

SEC Adopts Reforms Relating to Investment Advisers Operating Exclusively Through the Internet

Retrieved on: 
星期三, 三月 27, 2024

Washington, D.C.--(Newsfile Corp. - March 27, 2024) - The Securities and Exchange Commission today adopted amendments to the rule permitting certain internet investment advisers to register with the Commission (the “internet adviser exemption”).

Key Points: 
  • Washington, D.C.--(Newsfile Corp. - March 27, 2024) - The Securities and Exchange Commission today adopted amendments to the rule permitting certain internet investment advisers to register with the Commission (the “internet adviser exemption”).
  • The amendments will require an investment adviser relying on the internet adviser exemption to have at all times an operational interactive website through which the adviser provides digital investment advisory services on an ongoing basis to more than one client.
  • “These amendments modernize a 22-year-old rule to better protect investors in a digital age,” said SEC Chair Gary Gensler.
  • Most investment advisers will have filed their annual updating amendments to Form ADV by this date i.e., 90 days after the Dec. 31, 2024, fiscal year end).

Mobile-health Network Solutions Announces Pricing of $9 Million Initial Public Offering

Retrieved on: 
星期二, 四月 9, 2024

Singapore, April 09, 2024 (GLOBE NEWSWIRE) -- Mobile-health Network Solutions (“MNDR” or the “Company”), a leading telehealth solutions provider in Singapore, today announced the pricing of its firm commitment initial public offering of an aggregate 2,250,000 Class A Ordinary Shares (the “Offering”).

Key Points: 
  • Singapore, April 09, 2024 (GLOBE NEWSWIRE) -- Mobile-health Network Solutions (“MNDR” or the “Company”), a leading telehealth solutions provider in Singapore, today announced the pricing of its firm commitment initial public offering of an aggregate 2,250,000 Class A Ordinary Shares (the “Offering”).
  • The Offering is priced at $4.00 per share (the “Offering Price”).
  • Assuming that the Over-allotment is exercised, the Company is expected to receive gross proceeds amounting to $10.35 million, before deducting underwriting discounts and commissions and estimated offering expenses.
  • Network 1 Financial Securities, Inc. (“Network 1”), a full-service broker/dealer, acted as the sole book-running manager for the Offering.

Diamondback Energy Prices Offering of Senior Notes

Retrieved on: 
星期二, 四月 9, 2024

MIDLAND, Texas, April 09, 2024 (GLOBE NEWSWIRE) -- Diamondback Energy, Inc. (NASDAQ: FANG) (“Diamondback”) announced today that it has priced an offering (the “Notes Offering”) of $850,000,000 in aggregate principal amount of 5.200% senior notes that will mature on April 18, 2027 (the “2027 Notes”), $850,000,000 in aggregate principal amount of 5.150% senior notes that will mature on January 30, 2030 (the “2030 Notes”), $1,300,000,000 in aggregate principal amount of 5.400% senior notes that will mature on April 18, 2034 (the “2034 Notes”), $1,500,000,000 in aggregate principal amount of 5.750% senior notes that will mature on April 18, 2054 (the “2054 Notes”) and $1,000,000,000 in aggregate principal amount of 5.900% senior notes that will mature on April 18, 2064 (the “2064 Notes” and, together with the 2027 Notes, the 2030 Notes, the 2034 Notes and the 2054 Notes, the “Notes”).

Key Points: 
  • MIDLAND, Texas, April 09, 2024 (GLOBE NEWSWIRE) -- Diamondback Energy, Inc. (NASDAQ: FANG) (“Diamondback”) announced today that it has priced an offering (the “Notes Offering”) of $850,000,000 in aggregate principal amount of 5.200% senior notes that will mature on April 18, 2027 (the “2027 Notes”), $850,000,000 in aggregate principal amount of 5.150% senior notes that will mature on January 30, 2030 (the “2030 Notes”), $1,300,000,000 in aggregate principal amount of 5.400% senior notes that will mature on April 18, 2034 (the “2034 Notes”), $1,500,000,000 in aggregate principal amount of 5.750% senior notes that will mature on April 18, 2054 (the “2054 Notes”) and $1,000,000,000 in aggregate principal amount of 5.900% senior notes that will mature on April 18, 2064 (the “2064 Notes” and, together with the 2027 Notes, the 2030 Notes, the 2034 Notes and the 2054 Notes, the “Notes”).
  • The Notes Offering is expected to close on April 18, 2024, subject to customary closing conditions.
  • The Notes will be sold in a registered offering pursuant to an effective shelf registration statement on Form S-3ASR that was previously filed with the Securities and Exchange Commission, a prospectus supplement and related base prospectus for the Notes Offering.
  • Citigroup Global Markets Inc., BofA Securities, Inc. and TD Securities (USA) LLC have served as joint book-running managers for the Notes Offering.

INNOVATE Corp. Announces Further Extension of Rights Offering Subscription Period

Retrieved on: 
星期二, 四月 9, 2024

NEW YORK, April 09, 2024 (GLOBE NEWSWIRE) -- INNOVATE Corp. (“INNOVATE” or the “Company”) (NYSE: VATE), a diversified holding company, announced today that its Board of Directors has extended the subscription period for its rights offering to 5:00 p.m. Eastern Time on April 19, 2024, in order to allow stockholders and noteholders who are entitled to participate in the rights offering (holders of record of the Company’s common stock, Series A-3 Preferred Stock, Series A-4 Preferred Stock and 2026 Convertible Notes as of 5:00 p.m. Eastern Time on March 6, 2024) additional time to participate.

Key Points: 
  • NEW YORK, April 09, 2024 (GLOBE NEWSWIRE) -- INNOVATE Corp. (“INNOVATE” or the “Company”) (NYSE: VATE), a diversified holding company, announced today that its Board of Directors has extended the subscription period for its rights offering to 5:00 p.m. Eastern Time on April 19, 2024, in order to allow stockholders and noteholders who are entitled to participate in the rights offering (holders of record of the Company’s common stock, Series A-3 Preferred Stock, Series A-4 Preferred Stock and 2026 Convertible Notes as of 5:00 p.m. Eastern Time on March 6, 2024) additional time to participate.
  • The rights offering was initially scheduled to expire at 5:00 p.m. Eastern Time on March 25, 2024 and the expiration date was previously extended until 5:00 p.m. Eastern Time on April 9, 2024.
  • The rights offering is being made pursuant to INNOVATE’s effective shelf registration statement on Form S-3, filed with the SEC on September 29, 2023 and declared effective on October 6, 2023, and a prospectus supplement containing the detailed terms of the rights offering originally filed with the SEC on March 8, 2024, as amended on March 23, 2024 and April 9, 2024.
  • The rights offering was made only by means of a prospectus and a related prospectus supplement, copies of which were distributed to all eligible rights holders as of the rights offering record date and may also be obtained free of charge at the website maintained by the SEC at www.sec.gov or by contacting the information agent for the rights offering.

Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Ventyx, and Anavex and Encourages Investors to Contact the Firm

Retrieved on: 
星期二, 四月 9, 2024

The Company's lead clinical product candidate is VTX958, a selective allosteric tyrosine kinase type 2 inhibitor for psoriasis, psoriatic arthritis, and Crohn's disease.

Key Points: 
  • The Company's lead clinical product candidate is VTX958, a selective allosteric tyrosine kinase type 2 inhibitor for psoriasis, psoriatic arthritis, and Crohn's disease.
  • In addition, throughout the Class Period, Defendants made materially false and misleading statements regarding the Company's business, operations, and prospects.
  • On November 6, 2023, during after-market hours, Ventyx issued a press release announcing results from the Phase 2 SERENITY Trial.
  • For more information on the Anavex class action go to: https://bespc.com/cases/AVXL